Solventum SOLV
$
Relative Strength Index (RSI)
- The Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. It is typically used to identify overbought or oversold conditions in financial markets.
- The RSI is calculated using the following formula:
RSI = 100 - (100 / (1 + RS))
Where RS is the ratio of the average gains to the average losses over a specified period.
- The default time period used is 14 days.
- RSI values range between 0 and 100.
RSI values above 70 are considered overbought (indicating a potentially opportune time to sell)
RSI values below 30 are considered oversold (indicating a potentially opportune time to buy)
RSI is not a perfect indicator and should be used in conjunction with other technical analysis tools, this is for informational purposes only and is not a substitute for professional financial advice.
Key Insights
Solventum (SOLV) Core Market Data and Business Metrics
Latest Closing Price
$76.62Price-Earnings Ratio
27.76Total Outstanding Shares
173 Million SharesDividend
No dividendSIC Description
Surgical & Medical Instruments & ApparatusPrimary Exchange
New York Stock ExchangeHeadquarters
C/o 3m Company, St. Paul, MN, 55144-1000
Historical Stock Splits
| Execution Date | Split Amount |
|---|---|
| No Historical Stock Splits | |
Short Interest
Track Short Interest Levels to Gauge Bearish Market Sentiment and Short Squeeze Potential
| Avg Daily Volume | Days to Cover | Settlement Date | Short Interest |
|---|---|---|---|
| 1,172,014 Shares | 3.7 | 3/14/2025 | 4,341,304 Shares |
| 1,386,046 Shares | 3.1 | 2/28/2025 | 4,292,511 Shares |
| 719,954 Shares | 5.81 | 2/14/2025 | 4,181,958 Shares |
| 955,290 Shares | 4.66 | 1/31/2025 | 4,452,110 Shares |
| 1,096,559 Shares | 3.97 | 1/15/2025 | 4,348,022 Shares |
| 756,151 Shares | 5.82 | 12/31/2024 | 4,404,476 Shares |
Cash Flow Statement
January 1, 2024 to December 31, 2024
| Metric | Value |
|---|---|
| Net Cash Flow From Operating Activities, Continuing | $1.19 Billion |
| Net Cash Flow From Financing Activities | $-240 Million |
| Net Cash Flow | $565 Million |
| Net Cash Flow From Operating Activities | $1.19 Billion |
| Net Cash Flow From Investing Activities | $-380 Million |
| Net Cash Flow From Investing Activities, Continuing | $-380 Million |
Income Statement
January 1, 2024 to December 31, 2024
| Metric | Value |
|---|---|
| Preferred Stock Dividends And Other Adjustments | $0 |
| Diluted Earnings Per Share | $2.76 |
| Costs And Expenses | $7.65 Billion |
| Cost Of Revenue | $3.66 Billion |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0 |
| Operating Income/Loss | $1.04 Billion |
Comprehensive Income
January 1, 2024 to December 31, 2024
| Metric | Value |
|---|---|
| Other Comprehensive Income/Loss Attributable To Parent | $-188 Million |
| Other Comprehensive Income/Loss | $291 Million |
| Comprehensive Income/Loss | $291 Million |
| Comprehensive Income/Loss Attributable To Parent | $291 Million |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0 |
Balance Sheet
January 1, 2024 to December 31, 2024
| Metric | Value |
|---|---|
| Other Non-current Liabilities | $785 Million |
| Noncurrent Liabilities | $8.79 Billion |
| Liabilities And Equity | $14.46 Billion |
| Current Assets | $3.25 Billion |
| Equity Attributable To Noncontrolling Interest | $0 |
| Equity Attributable To Parent | $2.96 Billion |
Historical Dividends
| Announcement Date | Payment Date | Record Date | Amount | Frequency |
|---|---|---|---|---|
| No historical dividends | ||||